Advisory Board

+ DR. NORMAN G. LEWIS

  • Chief Research Scientist at the New Mexico Consortium, with over 40 years experience as a biochemist
  • Research Fellow at the New Center for Genomic Resources and President at Ealasid Inc.
  • Current research interests are largely in discovering/studying/modifying plant biochemical pathways, as well as with bioenergy/bioproducts and medicinal plant biosynthetic pathway research

+ DR. HECTOR QUEMADA

  • Director of Biosafety Resource Network at the Donald Danforth Plant Science Center
  • Independent consultant for the Gates Foundation and Monsanto
  • Expert in regulatory affairs within the biotechnology space

+ DR. AMANDA SIMCOX

  • Professor for the Department of Molecular Genetics at Ohio State University
  • Expertise in molecular biology and genetics, currently studying EGF receptor signalling in the early wing disc

+ DR. MAX ARELLA

  • Over 30 years experience in academic research, scientific consultation and start-up technological companies
  • Expertise in international affairs for the development and implementation of projects in advanced technology

+ DR. DAVID KERR

  • Intellectual property lawyer partner at Berg Hill Greenleaf Ruscitti, LLP
  • Specialises in intellectual property litigation, including both enforcement and defense of traditional intellectual property rights such as patent, trademark and copyrights, as well as unfair competition, misappropriation and trade secret matters